ADVANCED HODGKIN LYMPHOMA
Clinical trials for ADVANCED HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ADVANCED HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New approach personalizes cancer treatment using scans to guide therapy
Disease control Recruiting nowThis study is testing a personalized treatment strategy for people with advanced Hodgkin lymphoma. Participants receive initial immunotherapy combined with chemotherapy, then their treatment is adjusted based on how well they respond to the first two cycles, as measured by PET sc…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Research Center for Hematology, Russia • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
Blood test could spare cancer patients from unnecessary chemotherapy
Disease control Recruiting nowThis study is testing whether a blood test can safely reduce chemotherapy for people with advanced Hodgkin lymphoma. After two initial chemo cycles, patients with no detectable cancer DNA in their blood will receive less total treatment. The goal is to control the cancer while mi…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Shorter, stronger treatment tested for tough blood cancer
Disease control Recruiting nowThis study is testing a shorter version of a powerful six-drug chemotherapy combination (called BrECADD) for adults with advanced Hodgkin lymphoma. The main goal is to see if this shorter treatment plan can effectively control the cancer while being more tolerable for patients. R…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC